Strategic Management and Sustainability

Strategic
management and
Sustainability.

Table of Contents
INTRODUCTION ..........................................................................................................................1
MAIN BODY ..................................................................................................................................1
Internal analysis of Astrazencea and it's sector in relation to their internal approach to
business strategy ....................................................................................................................1
Existing business strategy of the company ............................................................................2
VRIO analysis and strategic capabilities of the company using SWOT analysis..................3
SWOT Analysis:.....................................................................................................................3
Implementation of environmental sustainability by AstraZencea:.........................................5
Key findings ..........................................................................................................................6
CONCLUSION ...............................................................................................................................7
RECOMMENDATIONS ................................................................................................................8
REFERENCES................................................................................................................................9

INTRODUCTION
The COVID-29 pandemic has caused global impact and has affected the corporate world
with producing negative impact for various industries. The pharmaceutical industry in one of the
major industry which ha been impacted by the COVID-19 pandemic. This is because the
pandemic has created an urgency of producing an effective vacancies for the COVID-19 virus.
The production of the vaccine need to be completed on a large scale in order to meet the global
demand .The pharmaceutical business firm AstraZeneca is the basis of the firm. AstraZeneca is a
British Swedish multinational corporation which operates in the pharmaceutical and
biotechnology industry. The company has developed the Oxford-AstraZenecea Vaccine which is
currently being used for COVID-19 vaccination. This report includes identification of business
strategies of the company from the past five years with discussion with the help of suitable
framework. Resources and capabilities of the respective company are provided in this report
along with analysis of extent to which alignment of business strategies with resources and
capabilities of the company. Evidence to implementation of environmental sustainability is
provided in this report with ways of thinking to become more competitive.
MAIN BODY
Internal analysis of Astrazencea and it's sector in relation to their internal approach to business
strategy
PORTER'S GENRIC STRATEGIES
These strategies describe ways in which the company can pursue competitive advantage
in their industry. Business organisations can use these strategies to gain competitive advantage in
their industry. Porter's generic strategies applied to the British Swedish multinational
pharmaceutical company AstraZeneca is provided below:
Cost leadership strategy: This strategy provided the company competitive advantage in
their industry by focusing on attracting cost sensitive consumers (Alberti, F.G. and Garrido,
M.A.V., 2017.). In order to adopt this strategy, business organisations need to lower overall costs
of their firm and offer high quality products at industry average prices. Business organisations
which utilise this strategy are able to increase their market share as the products or services
offered by the organisation are offered at industry average prices. In respect to AstraZeneca,
they gains profitability with the help of this strategy by lowering overall costs of the company.
1

This helps their company increase their market share while ensuring high profitability. This
results in the company gaining leading position in their industry and secure competitive
advantage in their firm.
Differentiation strategy: The strategy is centred around creation of unique product or
services which has differentiated characteristics and product of the company provide additional
value to the consumer base. In respect to AstraZeneca, they utilise this strategy and need to
conduct heavy research on their target consume base in order to provide innovative product or
service which solve the problems of the consumers.
Focus strategy : This strategy focusses on targeting their product in a particular market
and to a particular type of audience (Alonso-Almeida and et. al., 2018.). In context to
AstraZeneca, their particular segment of audience are patients which are in need of affordable
medical support.
Existing business strategy of the company
In order to give a complete overview of the business strategy which is followed by the
AstraZeneca from the last five years Ansoff analysis is given below:
Market Penetration: By this strategy the company tries to increase its market share with
the help of its existing offerings such as products and services in existing market. The company
tries to increase its sale in the existing market with the help of aggressive promotion and
distribution strategies or by decreasing the price of the products and services. In context to
AstraZeneca, they have a strong sales and marketing structure and also they have entered the
generic realm of pharmaceuticals which enable them to provide medicines on a reasonable price
to the consumers.
Market development: In this strategy the company tries to capture new markets with the
help of existing products and services (Arnold, M., 2017.). The company tries to enter another
geographical area or different customer segment which can help the company in increasing their
sales as well as market share. In respect to AstraZeneca, they are providing oncology medication
for which they entered the market of U.S with the product called Crester. The product was highly
successful because the rate of people with obesity and cholesterol is higher in U.S then any other
country.
Product development: With the help of this strategy the company tries to increase sales
and market share in the existing market but with a new product or services. It can be achieved by
2